EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Research Progress on the Molecular Mechanism of Metformin Regulating AMPK Signaling Pathway in Inhibiting Liver Cancer

Hong Bin Zhang, Yan Yan, Jin Peng Pang, Meng Ting Kong, Qian Kun Zhu

OncoTargets and Therapy · 2026-02 · Volume 19 · 1-19

DOI: 10.2147/ott.s572872 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift OncoTargets and Therapy, 2026-02. Verfasst von Hong Bin Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Radiology Department, Affiliated Fourth Hospital, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China. Die Arbeit nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver cancer is one of the common malignant tumors worldwide and ranks among the top in cancer mortality statistics. In recent years, metformin, as a first-line drug with significant efficacy and low cost, has been widely used in clinical practice for the treatment of diabetes. Now, due to its potential inhibitory effect on cancer cells, it has received extensive attention. In view of this, a large number of studies have focused on the mechanisms by which metformin affects Liver carcinoma, with the AMPK pathway being particularly favored. This is because the AMPK pathway plays a significant role in autophagy, cell cycle arrest, inhibition of tumor angiogenesis, and suppression of epithelial-mesenchymal transition. To this end, we reviewed relevant research literature and systematically explored the mechanism of metformin's treatment of liver cancer through the AMPK pathway and its potential clinical applications. These studies provide an important basis for understanding the potential role of metformin in the treatment of liver cancer and provide important reference for future research on its new mechanisms and its clinical application.

Schlagwörter

Stichwörter der Autor:innen

AMPKautophagycell cycle arrestdrug synergyliver cancer

Autor:innen und Institutionen

  • Interventional Radiology Department, Affiliated Fourth Hospital, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China.

Zitieren

APA

Zhang, H. B., Yan, Y., Pang, J. P., Kong, M. T., & Zhu, Q. K. (2026). Research Progress on the Molecular Mechanism of Metformin Regulating AMPK Signaling Pathway in Inhibiting Liver Cancer. OncoTargets and Therapy, Volume 19, 1-19. https://doi.org/10.2147/ott.s572872

Vancouver

Zhang HB, Yan Y, Pang JP, Kong MT, Zhu QK. Research Progress on the Molecular Mechanism of Metformin Regulating AMPK Signaling Pathway in Inhibiting Liver Cancer. OncoTargets and Therapy. 2026;Volume 19:1-19. doi:10.2147/ott.s572872

BibTeX
@article{Zhang2026,
  author = {Zhang, Hong Bin and Yan, Yan and Pang, Jin Peng and Kong, Meng Ting and Zhu, Qian Kun},
  title = {Research Progress on the Molecular Mechanism of Metformin Regulating AMPK Signaling Pathway in Inhibiting Liver Cancer},
  journal = {OncoTargets and Therapy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--19},
  doi = {10.2147/ott.s572872}
}
Kostenlos starten →